Acorah Software Products - Accounts Production 16.1.200 false true 31 August 2023 1 September 2022 false 1 September 2023 31 August 2024 31 August 2024 11539871 Gabriel Sabban iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11539871 2023-08-31 11539871 2024-08-31 11539871 2023-09-01 2024-08-31 11539871 frs-core:CurrentFinancialInstruments 2024-08-31 11539871 frs-core:RevaluationReserve 2023-08-31 11539871 frs-core:RevaluationReserve 2024-08-31 11539871 frs-core:ShareCapital 2024-08-31 11539871 frs-core:RetainedEarningsAccumulatedLosses 2024-08-31 11539871 frs-bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 11539871 frs-bus:FilletedAccounts 2023-09-01 2024-08-31 11539871 frs-bus:SmallEntities 2023-09-01 2024-08-31 11539871 frs-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 11539871 frs-bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 11539871 frs-bus:Director1 2023-09-01 2024-08-31 11539871 frs-countries:EnglandWales 2023-09-01 2024-08-31 11539871 2022-08-31 11539871 2023-08-31 11539871 2022-09-01 2023-08-31 11539871 frs-core:CurrentFinancialInstruments 2023-08-31 11539871 frs-core:RevaluationReserve 2023-08-31 11539871 frs-core:ShareCapital 2023-08-31 11539871 frs-core:RetainedEarningsAccumulatedLosses 2023-08-31
Registered number: 11539871
NEWMED SOLUTION LIMITED
Unaudited Financial Statements
For The Year Ended 31 August 2024
Wizz Accounting Ltd
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 11539871
2024 2023
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 9,854 9,854
Cash at bank and in hand 309,030 317,404
318,884 327,258
Creditors: Amounts Falling Due Within One Year 5 (317,642 ) (317,642 )
NET CURRENT ASSETS (LIABILITIES) 1,242 9,616
TOTAL ASSETS LESS CURRENT LIABILITIES 1,242 9,616
NET ASSETS 1,242 9,616
CAPITAL AND RESERVES
Called up share capital 6 1 1
Revaluation reserve 7 11,770 11,770
Profit and Loss Account (10,529 ) (2,155 )
SHAREHOLDERS' FUNDS 1,242 9,616
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Gabriel Sabban
Director
31 December 2024
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
NEWMED SOLUTION LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 11539871 . The registered office is 128 City Road, London, EC1V 2NX.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
4. Debtors
2024 2023
£ £
Due within one year
Other debtors 9,853 9,853
Called up share capital not paid 1 1
9,854 9,854
5. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Accruals and deferred income 132 132
Director's loan account 317,510 317,510
317,642 317,642
6. Share Capital
2024 2023
£ £
Called Up Share Capital not Paid 1 1
Amount of Allotted, Called Up Share Capital 1 1
7. Reserves
Revaluation Reserve
£
As at 1 September 2023 11,770
As at 31 August 2024 11,770
Page 2